For a viable, going concern I agree. But for organisations using the platform to pay themselves & with no real "product" to generate a return for investors is counter to what I would call prudent. Just my opinion though........
Ann: BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL, page-55
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.010(35.7%) |
Mkt cap ! $16.24M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.5¢ | 1.8¢ | $365.2K | 18.41M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 1498942 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 40000 | 1 |
View Market Depth
| Last trade - 15.58pm 06/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |